Background: Sublingual immunotherapy (SLIT) is a safe and effective treatment for allergic rhinitis (AR). However, many issues regarding SLIT remain to be resolved, including the optimal timing of administration. This study investigated the effect of time of day on SLIT efficacy with the goal of optimizing the therapeutic outcome. Methods: We performed prophylactic SLIT at different times of day (10 a.m. or 10 p.m.) in 2 mouse models of AR: an ovalbumin (OVA)-induced AR model and Cry j 1-induced AR model, and compared the effects. Results: In the OVA-induced AR model, mice sublingually receiving OVA at 10 a.m. exhibited a greater decrease in total and OVA-specific IgE levels than mice treated at 10 p.m. In addition, mice treated at 10 a.m. exhibited reductions in OVA-specific IL-4, IL-10, and IL-13 production by splenocytes relative to mice treated at 10 p.m. Furthermore, we observed a more efficient capture of sublingually administered OVA in submandibular lymph nodes at 10 a.m. than at 10 p.m. in mice. Similar results were observed in the Cry j 1-induced AR model using Japanese cedar pollen extract for SLIT. Conclusions: Given the allergen-specific antibody and T cell responses, we suggest that SLIT may be more effective in the resting phase than in the active phase (note that mice are nocturnal animals). Thus, we propose that a chronotherapeutic approach should be considered for SLIT to maximize its effectiveness.

1.
Radulovic S, Wilson D, Calderon M, Durham S: Systematic reviews of sublingual immunotherapy (SLIT). Allergy 2011;66:740-752.
2.
Dretzke J, Meadows A, Novielli N, Huissoon A, Fry-Smith A, Meads C: Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: a systematic review and indirect comparison. J Allergy Clin Immunol 2013;131:1361-1366.
3.
Pleskovic N, Bartholow A, Gentile DA, Skoner DP: The future of sublingual immunotherapy in the United States. Curr Allergy Asthma Rep 2015;15:44.
4.
Brimnes J, Kildsgaard J, Jacobi H, Lund K: Sublingual immunotherapy reduces allergic symptoms in a mouse model of rhinitis. Clin Exp Allergy 2007;37:488-497.
5.
Mascarell L, Saint-Lu N, Moussu H, Zimmer A, Louise A, Lone Y, Ladant D, Leclerc C, Tourdot S, van Overtvelt L, Moingeon P: Oral macrophage-like cells play a key role in tolerance induction following sublingual immunotherapy of asthmatic mice. Mucosal Immunol 2011;4:638-647.
6.
Yamada T, Saito H, Fujieda S: Present state of Japanese cedar pollinosis: the national affliction. J Allergy Clin Immunol 2014;133:632-639.e5.
7.
Dallmann R, Brown SA, Gachon F: Chronopharmacology: new insights and therapeutic implications. Annu Rev Pharmacol Toxicol 2014;54:339-361.
8.
Smolensky MH, Lemmer B, Reinberg AE: Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma. Adv Drug Deliv Rev 2007;59:852-882.
9.
Nakamura Y, Harama D, Shimokawa N, Hara M, Suzuki R, Tahara Y, Ishimaru K, Katoh R, Okumura K, Ogawa H, Shibata S, Nakao A: Circadian clock gene Period2 regulates a time-of-day-dependent variation in cutaneous anaphylactic reaction. J Allergy Clin Immunol 2011;127:1038-1045.
10.
Nakamura Y, Nakano N, Ishimaru K, Hara M, Ikegami T, Tahara Y, Katoh R, Ogawa H, Okumura K, Shibata S, Nishiyama C, Nakao A: Circadian regulation of allergic reactions by the mast cell clock in mice. J Allergy Clin Immunol 2014;133:568-575.e12.
11.
Nakao A, Nakamura Y, Shibata S: The circadian clock functions as a potent regulator of allergic reaction. Allergy 2015;70:467-473.
12.
Dibner C, Schibler U, Albrecht U: The mammalian circadian timing system: organization and coordination of central and peripheral clocks. Annu Rev Physiol 2010;72:517-549.
13.
Mohawk JA, Green CB, Takahashi JS: Central and peripheral circadian clocks in mammals. Annu Rev Neurosci 2012;35:445-462.
14.
Scheiermann C, Kunisaki Y, Frenette PS: Circadian control of the immune system. Nat Rev Immunol 2013;13:190-198.
15.
Keller M, Mazuch J, Abraham U, Eom GD, Herzog ED, Volk HD, Kramer A, Maier B: A circadian clock in macrophages controls inflammatory immune responses. Proc Natl Acad Sci USA 2009;106:21407-21412.
16.
Zhang C, Ohno T, Kang S, Takai T, Azuma M: Repeated antigen painting and sublingual immunotherapy in mice convert sublingual dendritic cell subsets. Vaccine 2014;32:5669-5676.
17.
MacSharry J, Shalaby KH, Marchica C, Farahnak S, Chieh-Li T, Lapthorne S, Qureshi ST, Shanahan F, Martin JG: Concomitant exposure to ovalbumin and endotoxin augments airway inflammation but not airway hyperresponsiveness in a murine model of asthma. PLoS One 2014;9:e98648.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.